(4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoate

Term ID

CHEBI:77015

Synonyms

(4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosa-4,7,10,13,16,19-hexaenoate
22-hydroxy-(4Z,7Z,10Z,13Z,16Z,19Z)-DHA(1-)
22-hydroxy-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate
22-OH-C22:6(omega-3)(1-)

Definition

A polyunsaturated fatty acid anion that is the conjugate base of (4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: hydroxy polyunsaturated fatty acid anion omega-hydroxy-long-chain fatty acid anion

hydroxy polyunsaturated fatty acid anion omega-hydroxy-long-chain fatty acid anion Show first 5 Terms
inverse is_conjugate_acid_of: (4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoic acid

(4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoic acid Show first 5 Terms
is_conjugate_base_of: (4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoic acid

(4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoic acid Show first 5 Terms

Phenotype

Phenotype resulting from (4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoate

Phenotype where environments contain (4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoate

Phenotype modified by environments containing (4Z,7Z,10Z,13Z,16Z,19Z)-22-hydroxydocosahexaenoate

Human Disease Model